These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1344004)

  • 1. So your patient is taking ... a calcium channel blocker (CCB)!
    Requa-Clark B
    J Dent Hyg; 1992 Oct; 66(8):369-71. PubMed ID: 1344004
    [No Abstract]   [Full Text] [Related]  

  • 2. Gingival hyperplasia associated with the use of calcium channel blockers.
    Volchansky A; Rosen M
    J Dent Assoc S Afr; 1997 Apr; 52(4):245-7. PubMed ID: 9462000
    [No Abstract]   [Full Text] [Related]  

  • 3. Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Ojeifo O; Wiviott SD; Antman EM; Murphy SA; Udell JA; Bates ER; Mega JL; Sabatine MS; O'Donoghue ML
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1275-81. PubMed ID: 24239201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calcium channel blocker for therapy of patients with hypertension].
    Sasaki S; Nakagawa M
    Nihon Rinsho; 1997 Aug; 55(8):2061-6. PubMed ID: 9284424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nifedipine-induced gingival enlargement around dental implants: a clinical report.
    Silverstein LH; Koch JP; Lefkove MD; Garnick JJ; Singh B; Steflik DE
    J Oral Implantol; 1995; 21(2):116-20. PubMed ID: 8699502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium channel blocker use and risk of Parkinson's disease: a meta-analysis.
    Lang Y; Gong D; Fan Y
    Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):559-66. PubMed ID: 25845582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new-generation N/L-type calcium channel blocker leads to less activation of the renin-angiotensin system compared with conventional L type calcium channel blocker.
    Konoshita T; Makino Y; Kimura T; Fujii M; Wakahara S; Arakawa K; Inoki I; Nakamura H; Miyamori I;
    J Hypertens; 2010 Oct; 28(10):2156-60. PubMed ID: 20625317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O; Andrews LM; Wang L; Xie L
    J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination effect of calcium channel blocker and valsartan on cardiovascular event prevention in patients with high-risk hypertension: ancillary results of the KYOTO HEART Study.
    Sawada T; Yamada H; Shiraishi J; Kimura S; Matsubara H
    Clin Exp Hypertens; 2012; 34(2):153-9. PubMed ID: 22008090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of calcium channel blocker on human sperm].
    Li L; Liu JH
    Zhonghua Nan Ke Xue; 2003 Dec; 9(9):700-2, 706. PubMed ID: 14727364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoepidemiologic detection of calcium channel blocker-induced change on digoxin clearance using multiple trough screen analysis.
    Suematsu F; Yukawa E; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y
    Biopharm Drug Dispos; 2002 Jul; 23(5):173-81. PubMed ID: 12116048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of intravenous lipid emulsions in the management of calcium channel blocker and β-blocker overdose: 3 years experience of a university hospital.
    Sebe A; Dişel NR; Açıkalın Akpınar A; Karakoç E
    Postgrad Med; 2015 Mar; 127(2):119-24. PubMed ID: 25684131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension.
    Kato J; Yokota N; Tamaki N; Kariya S; Kita T; Ayabe T; Eto T; Kitamura K
    Hypertens Res; 2011 Mar; 34(3):331-5. PubMed ID: 21124326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does your patient need a medical clearance?
    TDIC Risk Management Staff
    HDA Now; 2014; ():11. PubMed ID: 24712244
    [No Abstract]   [Full Text] [Related]  

  • 15. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The T- and L-type calcium channel blocker (CCB) mibefradil attenuates leg edema induced by the L-type CCB nifedipine in the spontaneously hypertensive rat: a novel differentiating assay.
    Major TC; Dhamija S; Black N; Liachenko S; Morenko B; Sobocinski G; Okerberg C; Tinholt P; Madore S; Kowala MC
    J Pharmacol Exp Ther; 2008 Jun; 325(3):723-31. PubMed ID: 18326812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nimodipine: test your drug IQ.
    Devlin MM
    Nursing; 2008 Jul; 38(7):56cc1-2. PubMed ID: 18580671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The patient with hypertension.
    Riley CK; Terezhalmy GT
    Quintessence Int; 2001 Oct; 32(9):671-90. PubMed ID: 11695136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of calcium channel blockers (CCB) for tocolysis in France and abroad].
    Parant O; Deudon R; Bennevent J; Viard C; Damase-Michel C; Guyard-Boileau B
    J Gynecol Obstet Biol Reprod (Paris); 2015 Apr; 44(4):312-23. PubMed ID: 25728784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-cardiogenic pulmonary edema and life-threatening shock due to calcium channel blocker overdose: a case report and clinical review.
    Siddiqi TA; Hill J; Huckleberry Y; Parthasarathy S
    Respir Care; 2014 Feb; 59(2):e15-21. PubMed ID: 23674813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.